Skip to main content
Home
  • About Terumo India
      1. Col 1
        1. About Terumo India
      2. Col 2
        1. Dear Stakeholders
        2. Who We Are
        3. At a Glance
        4. Terumo Group Identity
      3. Col 3
        1. Leadership Team
        2. History
        3. Terumo's Purpose
        4. Response to COVID-19
  • Business Overview
      1. Col 1
        1. Business Overview
      2. Col 2
        1. TIS Division (Terumo Interventional Systems)
        2. Cardiovascular Division (Terumo Cardiovascular)
        3. Vascular Graft Division (Terumo Aortic)
      3. Col 3
        1. Life Care Solutions Division
        2. Pharmaceutical Solutions Division
  • Sustainability
      1. col 1
        1. Sustainability
      2. col 2
        1. CSR Initiatives
        2. CSR Policy & Committee
      3. col 3
        1. Award & Recognition
        2. Creating a Diverse and Inclusive Workplace
  • Technology
      1. col 1
        1. Technology Overview
      2. col 2
        1. Basic Information
      3. col 3
        1. Stories - Our Technologies
  • News
      1. Col 1-4
        1. News
      2. Col 2-2
        1. Col 2-4
          • December 12, 2022
          • Financial
          • Notification of Completion of Acquisition and Cancellation of Own Shares (PDF 115.79 KB) (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
        2. Col 3-4
          • December 8, 2022
          • Corporate
          • Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France
        3. Col 4-4
          • December 06, 2022
          • Corporate
          • Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
  • Global Network
      1. Col 1
        1. Global Network
      2. Col 2
        1. Japan
        2. North America
        3. South America
      3. Col 3
        1. EMEA
        2. Greater China
        3. Asia and Pacific
  1. Home
  2. Technology
  3. Basic Information

Basic Information

Basic thinking and organization

banner

Introduces our basic thinking in areas including R&D and production, our organizational structure, our intellectual property, the Terumo Fellow program, and more.

Research and Development

Introduces the basic R&D thinking and global R&D organization of the Terumo Group.

Production and Supply

Introduces the production technology that sustains Terumo monozukuri, and the Terumo global production system.

Intellectual Property

Introduces the basic Terumo thinking regarding intellectual property, and patent-related information.

Terumo Fellows

Introduces the Terumo Fellow Program, which recognizes Terumo Associates who have outstanding expertise and experience in technology, research, and clinical development, and who make notable achievements in contributing to global healthcare.

Contact Us
Move to topTop

Revised MRP of Terumo’s Coronary Stent pdf

About Terumo

  • About Terumo
  • Dear Stakeholders
  • Who We Are
  • At a Glance
  • Terumo Group Identity
  • Leadership Team
  • History
  • Terumo's Purpose
  • Response to COVID-19

Business Overview

  • Business Overview
  • TIS Division (Terumo Interventional Systems)
  • Cardiovascular Division (Terumo Cardiovascular)
  • Vascular Graft Division (Terumo Aortic)
  • Life Care Solutions Division
  • Pharmaceutical Solutions Division

Sustainability

  • Sustainability Overview
  • CSR Initiatives
  • CSR Policy & Committee
  • Award & Recognition
  • Creating a Diverse and Inclusive Workplace

Technology

  • Technology Overview
  • Basic Information
    • Research and Development
    • Production and Supply
  • Stories - Our Technologies

Global Network

  • Japan
  • North America
  • South America
  • EMEA
  • Greater China
  • Asia and Pacific

Footer Bottom

  • Terms and Conditions of Use
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Site Map

Copyright © 2022 Terumo India Pvt Ltd, All Rights Reserved.